Creoptix

About:

Creoptix develops optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery industry.

Website: http://creoptix.com

Twitter/X: creoptix

Top Investors: Zürcher Kantonal Bank, Waters Corporation, Aargauische Kantonalbank, StartAngels Network, TR Invest

Description:

Creoptix is a private company headquartered in Wädenswil, near Zurich, Switzerland, with a US office in the Boston area. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix® WAVEsystem provides exceptionally high sensitivity and resolution to study real-time biological interactions involving small molecules, peptides, membrane proteins, biologics, and other molecules even in biofluids like undiluted serum or plasma. Engineered around the proprietary Grating-Coupled Interferometry (GCI) technology, the Creoptix® WAVEsystem delivers high-quality kinetic data across a broader range of samples than traditional SPR equipment.